These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Attaches the great importance of routine biopsy in vertebral augmentation].
    Author: Su QJ, Zhang YS.
    Journal: Zhonghua Wai Ke Za Zhi; 2020 Mar 01; 58(3):161-164. PubMed ID: 32187918.
    Abstract:
    Vertebral compression fractures(VCFs) are severe and common complications of osteoporosis. Most VCFs were caused by osteopenia or osteoporosis. Nevertheless, spinal metastases probably result in pathological fractures that easily confused with osteoporotic vertebral compression fractures(OVCFs). Using biopsy during vertebral augmentation(VA) is considered as the golden standard protocol to rule out pathological VCFs. Up to data, conventionally using biopsy during VA is suggested by more and more researchers to confirm the etiology of VCFs and to avoid missed diagnosis and misdiagnosis of spinal metastases with pathological vertebral fractures as the first manifestation. For patients with spinal metastases, histological evaluation of vertebral biopsy specimens is convenient for further treatment. 椎体压缩骨折是老年骨质疏松人群最常见的骨折类型。椎体压缩骨折大部分由骨量减低或骨质疏松症引起，小部分为脊柱转移瘤导致的病理性骨折，两者容易混淆。椎体强化术中活检是排除病理性椎体压缩骨折的金标准。目前，越来越多学者推荐在椎体强化术中进行常规活检以明确椎体压缩骨折的病因及诊断，避免以病理性椎体骨折为首发表现的转移癌的漏诊和误诊，对于转移癌患者，便于进行下一步治疗。.
    [Abstract] [Full Text] [Related] [New Search]